| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000018050 |
| Receipt No. | R000020659 |
| Official scientific title of the study | International survey on the present status of integrative medicine and the approach for it. |
| Date of disclosure of the study information | 2015/07/01 |
| Last modified on | 2017/06/25 (Ver. 6) |
| Basic information | |||||||
| Official scientific title of the study | International survey on the present status of integrative medicine and the approach for it. | ||||||
| Title of the study (Brief title) | International survey of integrative medicine | ||||||
| Region |
|
||||||
| Condition | |||
| Condition | adults aged 30 years or older with/without apparent illness | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To investigate the present status of integrative medicine and the approach for it in approximately 20 countries. |
| Basic objectives2 | Others |
| Basic objectives -Others | To consider the concept and the goal of integrative medicine |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | the similarity and the difference of integrative medicine between countries |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Those living in the relevant country for 10 years or more.
2. Those who are interested in integrative medicine. |
|||
| Key exclusion criteria | 1. Those who do not understand the meaning of this study.
2. Those who cannot answer the questionnaire of their own accord. 3. Those who are considered to be inappropriate as a participant. |
|||
| Target sample size | 1500 | |||
| Research contact person | |
| Name of lead principal investigator | Kiyoshi Suzuki |
| Organization | Gyokusenkai MOA Takanawa Clinic |
| Division name | President |
| Address | 4-8-10 Takanawa, Minato-ku, Tokyo |
| TEL | 03-5421-1945 |
| k.suzuki@mhs.or.jp | |
| Public contact | |
| Name of contact person | Kiyoshi Suzuki |
| Organization | Gyokusenkai MOA Takanawa Clinic |
| Division name | President |
| Address | 4-8-4-8-10 Takanawa, Minato-ku, Tokyo |
| TEL | 03-5421-1945 |
| Homepage URL | |
| k.suzuki@mhs.or.jp | |
| Sponsor | |
| Institute | MOA Health Science Foundation, the general incorporated foundation |
| Institute | |
| Department | |
| Funding Source | |
| Organization | MOA Health Science Foundation, the general incorporated foundation |
| Organization | |
| Division | |
| Category of Funding Organization | Non profit foundation |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | 1. The team delivers a lecture to volunteer investigators in the relevant countries, explaining the purposes of the study and giving guidance on how to administer the questionnaires.
2. The investigators explain the meaning of this study to the participants, preferably government officers or doctors, and obtain the answer of the questionnaire. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000020659 |